References
- Aderem A., Ulevitch R. J. Toll‐like receptors in the induction of the innate immune response. Nature 2000; 406: 782–787, [PUBMED], [INFOTRIEVE]
- Akira S. Toll‐like receptors and innate immunity. Adv. Immunol. 2001; 78: 1–56, [PUBMED], [INFOTRIEVE], [CSA]
- Arenzana‐Seisdedos F., Virelizier J. L., Fiers W. Interferons as macrophage‐activating factors. III. Preferential effects of interferon‐γ on the interleukin 1 secretory potential of fresh or aged human monocytes. J. Immunol. 1985; 134: 2444–2448
- Asea A., Rehli M., Kabingu E., Boch J. A., Baré O., Auron P. E., Stevenson M. A., Calderwood S. K. Novel signal transduction pathway utilized by extracellular HSP70. Role of Toll‐like receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002; 277: 15028–15034, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Baker P. J. The role of immune responses in bone loss during periodontal disease. Microbes Infect. 2000; 2: 1181–1192, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Darveau R. P., Belton C. M., Reife R. A., Lamont R. J. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect. Immun. 1998; 66: 1660–1665, [PUBMED], [INFOTRIEVE], [CSA]
- Darveau R. P., Arbabi S., Garcia I., Bainbridge B., Maier R. V. Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen‐activated protein kinase activation. Infect. Immun. 2002; 70: 1867–1873, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Delima A. J., Van Dyke T. E. Origin and function of the cellular components in gingival crevicular fluid. Periodontology 2000; 31: 55–76, [CROSSREF], [CSA]
- Durie F. H., Fava R. A., Foy T. M., Aruffo A., Ledbetter J. A., Noelle R. J. Prevention of collagen‐induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993; 261: 1328–1330, [PUBMED], [INFOTRIEVE]
- Ehlers M. R.W. CR3: a general purpose adhesion‐recognition receptor essential for innate immunity. Microbes Infect. 2000; 2: 289–294, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Elemer G., Edgington T. Monoclonal antibody to an activation neoepitope of αMβ2 inhibits multiple αMβ2 functions. J. Immunol. 1994; 152: 5836–5844, [PUBMED], [INFOTRIEVE]
- Genco R., Offenbacher S., Beck J. Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J. Am. Dent. Assoc. 2002; 133(Suppl.)14S–22S, [PUBMED], [INFOTRIEVE]
- Habich C., Baumgart K., Kolb H., Burkart V. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J. Immunol. 2002; 168: 569–576, [PUBMED], [INFOTRIEVE]
- Hajishengallis G., Genco R. J. Interactions of P. Gingivalis Fimbriae with Toll‐like Receptors (TLRs) and Co‐Receptors. 81st IADR General Session, GöteborgSweden, June, 25–282003
- Hajishengallis G., Martin M., Sojar H. T., Sharma A., Schifferle R. E., DeNardin E., Russell M. W., Genco R. J. Dependence of bacterial protein adhesins on Toll‐like receptors for proinflammatory cytokine induction. Clin. Diagn. Lab. Immunol. 2002a; 9: 403–411, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hajishengallis G., Sharma A., Russell M. W., Genco R. J. Interactions of oral pathogens with Toll‐like receptors: possible role in atherosclerosis. Ann. Periodontol. 2002b; 7: 72–78, [CSA]
- Hajishengallis G., Martin M., Schifferle R. E., Genco R. J. Counteracting interactions between lipopolysaccharide molecules with differential activation of Toll‐like receptors. Infect. Immun. 2002c; 70: 6658–6664, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Haraszthy V. I., Zambon J. J., Trevisan M., Zeid M., Genco R. J. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 2000; 71: 1554–1560, [PUBMED], [INFOTRIEVE]
- Haynes L. M., Moore D. D., Kurt‐Jones E. A., Finberg R. W., Anderson L. J., Tripp R. A. Involvement of Toll‐like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 2001; 75: 10730–10737, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hou L., Sasaki H., Stashenko P. Toll‐like receptor 4‐deficient mice have reduced bone destruction following mixed anaerobic infection. Infect. Immun. 2000; 68: 4681–4687, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Huo Y., Ley K. Adhesion molecules and atherogenesis. Acta Physiol. Scand. 2001; 173: 35–43, [PUBMED], [INFOTRIEVE], [CROSSREF]
- June C. H., Bluestone J. A., Nadler L. M., Thompson C. B. The B7 and CD28 receptor families. Immunol. Today 1994; 15: 321–331, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kalayoglu M. V., Perkins B. N., Byrne G. I. Chlamydia pneumoniae‐infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect. 2001; 3: 963–969, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Karin M., Delhase M. The IκB kinase (IKK) and NF‐κB: key elements of proinflammatory signalling. Semin. Immunol. 2000; 12: 85–98, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kastenbauer S., Zeigler‐Heitbrock H. W.L. NF‐κB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect. Immun. 1999; 67: 1553–1559, [PUBMED], [INFOTRIEVE], [CSA]
- Kawai T., Eisen‐Lev R., Seki M., Eastcott J. W., Wilson M. E., Taubman M. A. Requirement of B7 costimulation for Th1‐mediated inflammatory bone resorption in experimental periodontal disease. J. Immunol. 2000; 164: 2102–2109, [PUBMED], [INFOTRIEVE]
- Kawata Y., Hanazawa S., Amano S., Murakami Y., Matsumoto T., Nishida K., Kitano S. Porphyromonas gingivalis fimbriae stimulate bone resorption in vitro. Infect. Immun. 1994; 62: 3012–3016, [PUBMED], [INFOTRIEVE], [CSA]
- Kiechl S., Lorenz E., Reindl M., Wiedermann C. J., Oberhollenzer F., Bonora E., Willeit J., Schwartz D. A. Toll‐like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 2002; 347: 185–192, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kiener P. A., Moran‐Davis P., Rankin B. M., Wahl A. F., Aruffo A., Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 1995; 155: 4917–4925, [PUBMED], [INFOTRIEVE]
- Knoerzer D. B., Karr R. W., Schwartz B. D., Mengle‐Gaw L. J. Collagen‐induced arthritis in the BB rat: prevention of disease by treatment with CTLA‐4‐Ig. J. Clin. Invest. 1995; 96: 987–993, [PUBMED], [INFOTRIEVE], [CSA]
- Lamont R. J., Jenkinson H. F. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 1998; 62: 1244–1263, [PUBMED], [INFOTRIEVE], [CSA]
- Learn C. A., Mizel S. B., McCall C. E. mRNA and protein stability regulate the differential expression of pro‐ and anti‐inflammatory genes in endotoxin‐tolerant THP‐1 cells. J. Biol. Chem. 2000; 275: 12185–12193, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Li L., Cousart S., Hu J., McCall C. E. Characterization of interleukin‐1 receptor‐associated kinase in normal and endotoxin‐tolerant cells. J. Biol. Chem. 2000; 275: 23340–23345, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Li L., Messas E., Batista E. L.J., Levine R. A., Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E‐deficient murine model. Circulation 2002; 105: 861–867, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Liddington R. C., Ginsberg M. H. Integrin activation takes shape. J. Cell Biol. 2002; 158: 833–839, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Loesche W. J. Anaerobic periodontal infections as risk factors for medical diseases. Curr. Infect. Dis. Rep. 1999; 1: 33–38, [PUBMED], [INFOTRIEVE]
- Malek R., Fisher J. G., Caleca A., Stinson M., van Oss C. J., Lee J. Y., Cho M. I., Genco R. J., Evans R. T., Dyer D. W. Inactivation of Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J. Bacteriol. 1994; 176: 1052–1059, [PUBMED], [INFOTRIEVE]
- Malik N., Greenfield B. W., Wahl A. F., Kiener P. A. Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 1996; 156: 3952–3960, [PUBMED], [INFOTRIEVE]
- Medvedev A. E., Kopydlowski K. M., Vogel S. N. Inhibition of lipopolysaccharide‐induced signal transduction in endotoxin‐tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll‐like receptor 2 and 4 gene expression. J. Immunol. 2000; 164: 5564–5574, [PUBMED], [INFOTRIEVE]
- Medzhitov R., Janeway C. Innate immunity. N. Engl. J. Med. 2000; 343: 338–344, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Medzhitov R., Preston‐Hurlburt P., Janeway C. A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394–397, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mine S., Tabata T., Wada Y., Fujisaki T., Iida T., Noguchi N., Niki E., Kodama T., Tanaka Y. Oxidized low density lipoprotein‐induced LFA‐1‐dependent adhesion and transendothelial migration of monocytes via the protein kinase C pathway. Atherosclerosis 2002; 160: 281–288, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Modlin R. L., Brightbill H. D., Godowski P. J. The toll of innate immunity on microbial pathogens. N. Engl. J. Med. 1999; 340: 1834–1835, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Nagata H., Sharma A., Sojar H. T., Amano A., Levine M. J., Genco R. J. Role of the carboxyl‐terminal region of Porphyromonas gingivalis fimbrillin in binding to salivary proteins. Infect. Immun. 1997; 65: 422–427, [PUBMED], [INFOTRIEVE], [CSA]
- Njoroge T., Genco R. J., Sojar H. T., Hamada N., Genco C. A. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect. Immun. 1997; 65: 1980–1984, [PUBMED], [INFOTRIEVE], [CSA]
- Ogawa T., Uchida H., Hamada S. Porphyromonas gingivalis fimbriae and their synthetic peptides induce proinflammatory cytokines in human peripheral blood monocyte cultures. FEMS Microbiol. Lett. 1994; 116: 237–242, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- O'Neill L. A.J. Toll‐like receptor signal transduction and the tailoring of innate immunity: a role for Mal?. Trends Immunol. 2002; 23: 296–300, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Oxvig C., Lu C., Springer T. A. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain. PNAS 1999; 96: 2215–2220, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Poltorak A., He X., Smirnova I., Liu M. Y., Huffel C. V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi‐Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085–2088, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Qureshi S. T., Medzhitov R. Toll‐like receptors and their role in experimental models of microbial infection. Genes Immun. 2003; 4: 87–94, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rogy M. A., Coyle S. M., Oldenburg H. S., Rock C. S., Barie P. S., Van Zee K. J., Smith C. G., Moldawer L. L., Lowry S. F. Persistently elevated soluble tumor necrosis factor receptor and interleukin‐1 receptor antagonist levels in critically ill patients. J. Am. Coll. Surg. 1994; 178: 132–138, [PUBMED], [INFOTRIEVE], [CSA]
- Saito A., Sojar H. T., Genco R. J. Porphyromonas gingivalis surface components induce interleukin‐1 release and tyrosine phosphorylation in macrophages. FEMS Immunol. Med. Microbiol. 1996; 15: 51–57, [PUBMED], [INFOTRIEVE], [CSA]
- Schnare M., Barton G. M., Holt‐Czopic A., Takeda K., Akira S., Medzhitov R. Toll‐like receptors control activation of adaptive immune responses. Nat. Immunol. 2001; 2: 947–950, [PUBMED], [INFOTRIEVE]
- Sojar H. T., Lee J.‐Y., Genco R. J. Fibronectin binding domain of P. Gingivalis fimbriae. Biochem. Biophys. Res. Commun. 1995; 216: 785–792, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sojar H. T., Han Y., Hamada N., Sharma A., Genco R. J. Role of the amino‐terminal region of Porphyromonas gingivalis fimbriae in adherence to epithelial cells. Infect. Immun. 1999; 67: 6173–6176, [PUBMED], [INFOTRIEVE], [CSA]
- Sugawara S., Nemoto E., Tada H., Miyake K., Imamura T., Takada H. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J. Immunol. 2000; 165: 411–418, [PUBMED], [INFOTRIEVE]
- Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2‐deficient and MyD88‐deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 2000; 165: 5392–5396, [PUBMED], [INFOTRIEVE]
- Taubman M. A., Kawai T. Involvement of T‐lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit. Rev. Oral Biol. Med. 2001; 12: 125–135, [PUBMED], [INFOTRIEVE], [CSA]
- Underhill D. M. Toll‐like receptors: networking for success. Eur. J. Immunol. 2003; 33: 1767–1775, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vabulas R. M., Ahmad‐Nejad P., da Costa C., Miethke T., Kirschning C. J., Häcker H., Wagner H. Endocytosed HSP60s use Toll‐like receptor 2 (TLR2) and TLR4 to activate the Toll/Interleukin‐1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 2001; 276: 31332–31339, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vink A., Schoneveld A. H., van der Meer J. J., van Middelaar B. J., Sluijter J. P.G., Smeets M. B., Quax P. H.A., Lim S. K., Borst C., Pasterkamp G., de Kleijn D. P.V. In vivo evidence for a role of Toll‐like receptor 4 in the development of intimal lesions. Circulation 2002; 106: 1985–1990, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wooten R. M., Ma Y., Yoder R. A., Brown J. P., Weis J. H., Zachary J. F., Kirschning C. J., Weis J. J. Toll‐like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 2002; 168: 348–355, [PUBMED], [INFOTRIEVE]
- Yeh W.‐C., Chen N.‐J. Another toll road. Nature 2003; 424: 736–737, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yoshimura A., Kaneko T., Kato Y., Golenbock D. T., Hara Y. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll‐like receptor 4. Infect. Immun. 2002; 70: 218–225, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zambon J. J., Grossi S., Dunford R., Harazsthy V. I., Preus H., Genco R. J. Epidemiology of subgingival bacterial pathogens in periodontal diseases. Molecular Pathogenesis of Periodontal Disease, R. J. Genco, S. Hamada, J. R. Lehrer, J. R. McGhee, S. Mergenhangen. Am. Soc. Microbiol., Washington, DC, 3–12
- Ziegler‐Heitbrock H. W. Molecular mechanism in tolerance to lipopolysaccharide. J. Inflam. 1995; 45: 13–26, [CSA]
- Zuany‐Amorim C., Hastewell J., Walker C. Toll‐like receptors as potential therapeutic targets for multiple diseases. Nat. Rev. 2002; 1: 797–807